{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:16:04Z","timestamp":1787242564700,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ophtha.2016.06.055","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T18:38:38Z","timestamp":1470508718000},"page":"2166-2175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-292X","authenticated-orcid":false,"given":"Brian C.","family":"Toy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira H.","family":"Schachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin S.W.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius M.","family":"Moshfeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2016.06.055_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ophtha.2016.06.055_bib2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1542\/peds.65.6.1096","article-title":"Risk factors in retrolental fibroplasia","volume":"65","author":"Gunn","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2016.06.055_bib3","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1167\/iovs.08-2584","article-title":"Through the eyes of a child: understanding retinopathy through ROP. The Friedenwald lecture","volume":"49","author":"Smith","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2016.06.055_bib4","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2016.06.055_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ophtha.2010.04.021","article-title":"Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity","volume":"118","author":"Lepore","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.06.055_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2016.06.055_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2016.06.055_bib9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0161-6420(94)31301-7","article-title":"Postnatal retinal vascularization in former preterm infants with retinopathy of prematurity","volume":"101","author":"Mintz-Hittner","year":"1994","journal-title":"Ophthalmology"},{"issue":"3 Suppl","key":"10.1016\/j.ophtha.2016.06.055_bib11","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","article-title":"Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity","volume":"28","author":"Lalwani","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2016.06.055_bib12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2016.06.055_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bjophthalmol-2013-304109","article-title":"Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity","volume":"98","author":"Tahija","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib14","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/IAE.0b013e318275394a","article-title":"Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up","volume":"33","author":"Martinez-Castellanos","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2016.06.055_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archophthalmol.2010.145","article-title":"Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment","volume":"128","author":"Hoang","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.06.055_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2016.06.055_bib20","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.ophtha.2004.02.005","article-title":"Involution of threshold retinopathy of prematurity after diode laser photocoagulation","volume":"111","author":"Coats","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.06.055_bib21","first-page":"120","article-title":"Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy","volume":"18","author":"Henaine-Berra","year":"2014","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ophtha.2016.06.055_bib22","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings","volume":"121","author":"Lepore","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.06.055_bib23","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2016.06.055_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3928\/23258160-20160229-12","article-title":"Very late reactivation of retinopathy of prematurity after monotherapy with intravitreal bevacizumab","volume":"47","author":"Snyder","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ophtha.2016.06.055_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/aos.12266","article-title":"Intravitreal low-dosage bevacizumab for retinopathy of prematurity","volume":"92","author":"Harder","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","article-title":"An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan","volume":"155","author":"Wu","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/eye.2012.111","article-title":"Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity","volume":"26","author":"Lee","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2016.06.055_bib28","first-page":"323","article-title":"Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab","volume":"17","author":"Ittiara","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ophtha.2016.06.055_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcjo.2015.10.004","article-title":"Intravitreal bevacizumab for retinopathy of prematurity: considerations for informed consent","volume":"50","author":"Mireskandari","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00417-014-2867-0","article-title":"Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity\u201427 month follow-up results from Turkey","volume":"253","author":"Yetik","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib31","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ophtha.2015.04.023","article-title":"Influence of fluorescein angiography on the diagnosis and management of retinopathy of prematurity","volume":"122","author":"Klufas","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.06.055_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10384-014-0310-z","article-title":"Intravitreal injection of bevacizumab for retinopathy of prematurity","volume":"58","author":"Kuniyoshi","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib33","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/IAE.0b013e31820d3f70","article-title":"Management of avascular peripheral retina in older prematurely born infants","volume":"31","author":"Ho","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2016.06.055_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archopht.1977.04450020019002","article-title":"Retrolental fibroplasia: I. Clinical observations","volume":"95","author":"Flynn","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archopht.1977.04450010031002","article-title":"Retrolental fibroplasia. II. Pathologic correlation","volume":"95","author":"Kushner","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib37","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archopht.119.8.1110","article-title":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3928\/0191-3913-19940501-09","article-title":"Regression pattern in retinopathy of prematurity","volume":"31","author":"Preslan","year":"1994","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.ophtha.2016.06.055_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archopht.1990.01070040047029","article-title":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib40","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archopht.1990.01070120056029","article-title":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. One-year outcome\u2014structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 3","key":"10.1016\/j.ophtha.2016.06.055_bib41","first-page":"53","article-title":"Fluorescein angiography and retinal vascular development in premature infants","volume":"25","author":"Purcaro","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ophtha.2016.06.055_bib42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0161-6420(87)33401-3","article-title":"Retinopathy of prematurity. Diagnosis, severity, and natural history","volume":"94","author":"Flynn","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.06.055_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archopht.118.5.645","article-title":"Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"118","author":"Repka","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.06.055_bib44","article-title":"Peripheral retinal vascular patterns in patients with rhegmatogenous retinal detachment in Taiwan","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2016.06.055_bib45","article-title":"Current clinical evidence on the effect of general anesthesia on neurodevelopment in children: an updated systematic review with meta-regression","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2016.06.055_bib46","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/anae.12637","article-title":"General anaesthetics and the developing brain: an overview","volume":"69","author":"Sinner","year":"2014","journal-title":"Anaesthesia"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016305875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016305875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:08:49Z","timestamp":1656997729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016305875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0161642016305875"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.06.055","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.06.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}